Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Adagio Therapeutics, Inc. | Director, Other*, 10%+ Owner | Common Stock | 11.2M | $44.4M | $3.95 | Mar 28, 2022 | Indirect |
Fractyl Health, Inc. | Director, 10%+ Owner | Common Stock | 1.25M | Feb 6, 2024 | Indirect | ||
Fractyl Health, Inc. | Director, 10%+ Owner | Stock Option | 45K | Feb 1, 2024 | Direct | ||
Fractyl Health, Inc. | Director, 10%+ Owner | Series C-1 Preferred Stock | 0 | Feb 6, 2024 | Indirect | ||
Fractyl Health, Inc. | Director, 10%+ Owner | Series C-2 Preferred Stock | 0 | Feb 6, 2024 | Indirect | ||
Fractyl Health, Inc. | Director, 10%+ Owner | Series D Preferred Stock | 0 | Feb 6, 2024 | Indirect | ||
Fractyl Health, Inc. | Director, 10%+ Owner | Series E Preferred Stock | 0 | Feb 6, 2024 | Indirect | ||
Fractyl Health, Inc. | Director, 10%+ Owner | Series F Preferred Stock | 0 | Feb 6, 2024 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GUTS | Fractyl Health, Inc. | Feb 6, 2024 | 8 | $5M | 4 | Feb 8, 2024 | Director, 10%+ Owner |
GUTS | Fractyl Health, Inc. | Feb 1, 2024 | 1 | $0 | 4 | Feb 5, 2024 | Director |
GUTS | Fractyl Health, Inc. | Feb 1, 2024 | 0 | $0 | 3 | Feb 1, 2024 | Director, 10%+ Owner |
IVVD | Adagio Therapeutics, Inc. | Mar 28, 2022 | 0 | $0 | 4 | Mar 30, 2022 | Director, Other*, 10%+ Owner |
IVVD | Adagio Therapeutics, Inc. | Aug 10, 2021 | 5 | $33.9M | 4 | Aug 12, 2021 | Director, 10%+ Owner |
IVVD | Adagio Therapeutics, Inc. | Aug 5, 2021 | 1 | $0 | 4 | Aug 9, 2021 | Director, 10%+ Owner |
IVVD | Adagio Therapeutics, Inc. | Aug 5, 2021 | 0 | $0 | 3 | Aug 5, 2021 | Director, 10%+ Owner |